About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Seroquel XR in Schizophrenia Relapse Prevention

NCT00990626·48 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Schizophrenic outpatients on at least 600 mg Seroquel XR treatment for at least 1 month

You may not be if

Severe cerebro- and cardiovascular disease, severe hepatic impairment, gravidity

The record

StatusCompleted

PhaseNo phase

Taking part1,600

StartedOct 2009

UpdatedNov 17, 2010

Conditions

Schizophrenia Relapse Prevention

Where48

Research Site
Baja, Hungary
Research Site
Barcs, Hungary
Research Site
Budapest, Hungary

Clareo Health | Seroquel XR in Schizophrenia Relapse Prevention